Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Baseline Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios as Biomarkers of Survival in Cutaneous Melanoma: A Multicenter Cohort Study.

Wade RG, Robinson AV, Lo MCI, Keeble C, Marples M, Dewar DJ, Moncrieff MDS, Peach H.

Ann Surg Oncol. 2018 Jul 31. doi: 10.1245/s10434-018-6660-x. [Epub ahead of print]

PMID:
30066226
2.

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial.

Corrie PG, Marshall A, Nathan PD, Lorigan P, Gore M, Tahir S, Faust G, Kelly CG, Marples M, Danson SJ, Marshall E, Houston SJ, Board RE, Waterston AM, Nobes JP, Harries M, Kumar S, Goodman A, Dalgleish A, Martin-Clavijo A, Westwell S, Casasola R, Chao D, Maraveyas A, Patel PM, Ottensmeier CH, Farrugia D, Humphreys A, Eccles B, Young G, Barker EO, Harman C, Weiss M, Myers KA, Chhabra A, Rodwell SH, Dunn JA, Middleton MR; AVAST-M Investigators.

Ann Oncol. 2018 Jul 13. doi: 10.1093/annonc/mdy229. [Epub ahead of print]

PMID:
30010756
3.

Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial.

Seddon B, Strauss SJ, Whelan J, Leahy M, Woll PJ, Cowie F, Rothermundt C, Wood Z, Benson C, Ali N, Marples M, Veal GJ, Jamieson D, K├╝ver K, Tirabosco R, Forsyth S, Nash S, Dehbi HM, Beare S.

Lancet Oncol. 2017 Oct;18(10):1397-1410. doi: 10.1016/S1470-2045(17)30622-8. Epub 2017 Sep 4.

4.

Complications of bone metastases from malignant melanoma.

Zekri J, Marples M, Taylor D, Kandukurti K, McParland L, Brown JE.

J Bone Oncol. 2017 Aug 18;8:13-17. doi: 10.1016/j.jbo.2017.08.003. eCollection 2017 Sep.

5.

Adult Cancers in Adolescents and Young Adults.

Laurence V, Marples M, Stark DP.

Prog Tumor Res. 2016;43:64-73. doi: 10.1159/000447072. Epub 2016 Sep 5. Review.

PMID:
27595357
6.

Ipilimumab-induced colitis: experience from a tertiary referral center.

O'Connor A, Marples M, Mulatero C, Hamlin J, Ford AC.

Therap Adv Gastroenterol. 2016 Jul;9(4):457-62. doi: 10.1177/1756283X16646709. Epub 2016 May 10.

7.

Ipilimumab in the real world: the UK expanded access programme experience in previously treated advanced melanoma patients.

Ahmad SS, Qian W, Ellis S, Mason E, Khattak MA, Gupta A, Shaw H, Quinton A, Kovarikova J, Thillai K, Rao A, Board R, Nobes J, Dalgleish A, Grumett S, Maraveyas A, Danson S, Talbot T, Harries M, Marples M, Plummer R, Kumar S, Nathan P, Middleton MR, Larkin J, Lorigan P, Wheater M, Ottensmeier CH, Corrie PG.

Melanoma Res. 2015 Oct;25(5):432-42. doi: 10.1097/CMR.0000000000000185.

8.

Can D-Dimer Measurement Reduce the Frequency of Radiological Assessment in Patients Receiving Palliative Imatinib for Gastrointestinal Stromal Tumor (GIST)?

Afshar M, Hamilton P, Seligmann J, Lord S, Baxter P, Marples M, Stark D, Hall PS.

Cancer Invest. 2015;33(8):347-53. doi: 10.3109/07357907.2015.1047504. Epub 2015 Jul 2.

9.

Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study.

Corrie PG, Marshall A, Dunn JA, Middleton MR, Nathan PD, Gore M, Davidson N, Nicholson S, Kelly CG, Marples M, Danson SJ, Marshall E, Houston SJ, Board RE, Waterston AM, Nobes JP, Harries M, Kumar S, Young G, Lorigan P.

Lancet Oncol. 2014 May;15(6):620-30. doi: 10.1016/S1470-2045(14)70110-X. Epub 2014 Apr 15. Erratum in: Lancet Oncol. 2014 Aug;15(9):e365. Lancet Oncol. 2014 Jun;15(7):e253.

10.

Clinical impact of (18)F-FDG PET-CT in recurrent stage III/IV melanoma: a tertiary centre Specialist Skin Cancer Multidisciplinary Team (SSMDT) experience.

Subesinghe M, Marples M, Scarsbrook AF, Smith JT.

Insights Imaging. 2013 Oct;4(5):701-9. doi: 10.1007/s13244-013-0285-1. Epub 2013 Sep 10.

11.

Treatment patterns, outcomes, and resource utilization of patients with metastatic melanoma in the U.K.: the MELODY study.

Lorigan P, Marples M, Harries M, Wagstaff J, Dalgleish AG, Osborne R, Maraveyas A, Nicholson S, Davidson N, Wang Q, Pericleous L, Bapat U, Middleton MR.

Br J Dermatol. 2014 Jan;170(1):87-95. doi: 10.1111/bjd.12503.

PMID:
23855404
12.

Commentary: BRAF inhibitors for metastatic melanoma.

Marples M.

Br J Dermatol. 2013 Mar;168(3):471-3. doi: 10.1111/bjd.12240. No abstract available.

PMID:
23445312
13.

Patterns of expression of DNA repair genes and relapse from melanoma.

Jewell R, Conway C, Mitra A, Randerson-Moor J, Lobo S, Nsengimana J, Harland M, Marples M, Edward S, Cook M, Powell B, Boon A, de Kort F, Parker KA, Cree IA, Barrett JH, Knowles MA, Bishop DT, Newton-Bishop J.

Clin Cancer Res. 2010 Nov 1;16(21):5211-21. doi: 10.1158/1078-0432.CCR-10-1521. Epub 2010 Aug 12.

14.

Metastatic malignant melanoma of the conjunctiva: a case report.

Manidakis N, Polyzois I, Tsialogiannis E, Marples M, Boon A, Tsiridis E.

Cases J. 2009 Feb 4;2(1):125. doi: 10.1186/1757-1626-2-125.

15.

Sunitinib in the management of gastrointestinal stromal tumours (GISTs).

Hopkins TG, Marples M, Stark D.

Eur J Surg Oncol. 2008 Aug;34(8):844-50. Epub 2007 Dec 21. Review.

PMID:
18082353
16.

The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer.

Ward SE, Kaltenthaler E, Cowan J, Marples M, Orr B, Seymour MT.

Br J Cancer. 2006 Jul 3;95(1):27-34. Review.

17.

A phase I (tumour site-specific) study of carboplatin and temozolomide in patients with advanced melanoma.

Strauss SJ, Marples M, Napier MP, Meyer T, Boxall J, Rustin GJ.

Br J Cancer. 2003 Nov 17;89(10):1901-5.

18.

Use of CA-125 to define progression of ovarian cancer in patients with persistently elevated levels.

Rustin GJ, Marples M, Nelstrop AE, Mahmoudi M, Meyer T.

J Clin Oncol. 2001 Oct 15;19(20):4054-7.

PMID:
11600607
19.

Diminished oesophageal traction forces with swallowing in gastro-oesophageal reflux disease and in functional dysphagia.

Williams D, Thompson DG, Marples M, Heggie L, O'Hanrahan T, Bancewicz J.

Gut. 1994 Feb;35(2):165-71.

20.

Identification of an abnormal esophageal clearance response to intraluminal distention in patients with esophagitis.

Williams D, Thompson DG, Marples M, Heggie L, O'Hanrahan T, Mani V, Bancewicz J.

Gastroenterology. 1992 Sep;103(3):943-53.

PMID:
1499944

Supplemental Content

Loading ...
Support Center